JOURNAL OF MEDICINAL FOOD J Med Food 18 (5) 2015, 507–515 # Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition DOI: 10.1089/jmf.2014.0125
FULL COMMUNICATIONS
Therapeutic Potential of Ocimum tenuiflorum as MPO Inhibitor with Implications for Atherosclerosis Prevention Chandrakala Aluganti Narasimhulu and Sangamithra Vardhan Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA. ABSTRACT Current experimental studies show that Ocimum tenuiflorum (commonly known as basil or Tulsi) possesses many health benefits. Ocimum is suggested to be antioxidative and anti-inflammatory. Eugenol, an orthomethoxyphenol, and ursolic acid have been identified as important components of basil. Myeloperoxidase (MPO), an oxidative enzyme, has been implicated in the pathogenesis of atherosclerosis. MPO-dependent oxidation of lipoproteins has been implicated in foam cell formation, dysfunctional HDL, and abnormalities in reverse cholesterol transport. Whole leaf extract of O. tenuiflorum and its major components, eugenol and ursolic acid, inhibit the oxidation of lipoproteins by myeloperoxidase/copper as measured by conjugated diene formation as well as by the thiobarbituric acid reactive substance (TBARS) assay. Whole basil leaf extract is able to attenuate the lipopolysaccharide-induced inflammation in RAW 264.7 cells compared with its components. In addition, whole basil leaf extract and eugenol inhibited MPO enzyme activity against synthetic substrates. Based on these results, we conclude that basil extract could act as an inhibitor of MPO and may serve as a nonpharmacological therapeutic agent for atherosclerosis.
KEY WORDS: eugenol inflammation lipopolysaccharide lipoproteins oxidation ursolic acid
inhibition of lipid peroxidation,12 but the mechanisms of action are not yet known. Eugenol (4-allyl-2-methoxyphenol) is a naturally occurring phenolic compound in basil, cinnamon, and nutmeg and is the major component of clove oil. It is widely used as a component of zinc oxide eugenol cement in dentistry and is applied to the oral environment.13 In addition, eugenol is a flavoring agent in cosmetic and food products.14 Eugenol has been shown to possess many medicinal properties, such as antispasmodic,15 antipyretic,16 anti-inflammatory,17 and antibacterial activities.18 Recently, it is reported that eugenol inhibits 5-lipoxygenase enzyme by a noncompetitive mechanism.19 Ursolic acid (UA) is another component associated with basil and was identified as the major component in O. tenuiflorum.20 It has been reported that ursolic acid has protective properties similar to that of basil. Several mechanisms have been proposed to explain its anti-inflammatory activity, including inhibition of secretory phospholipase (PLA2) enzymes21 and inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).22 Existing evidence suggests that myeloperoxidase (MPO) plays a major role in the oxidative modification of both lowdensity lipoprotein (LDL) and high-density lipoprotein (HDL). MPO is a heme protein expressed at high levels in neutrophils, monocytes, and subpopulations of human macrophages. Catalytic activity of MPO is responsible for the generation of reactive intermediates that can promote further oxidation.23,24 One feature that distinguishes MPO
INTRODUCTION
P
lants have been the primary source of medicines for centuries. Several medicinal plants serve as potent sources of secondary metabolites and oils, which have gained therapeutic importance. Ocimum tenuiflorum is the queen of herbs, commonly known as holy basil or krishna tulsi.1 Numerous studies have reported various properties of Ocimum sp., including antimicrobial, adaptogenic, antidiabetic, hepatoprotective, anti-inflammatory, anticarcinogenic, radioprotective, immunomodulatory, neuroprotective, and cardioprotective, and its acting as a mosquito repellent.2–5 The major constituents in O. tenuiflorum are essential oils, carbohydrates, flavanoids, proline, high amount of linalool, and moderate amounts of methyl chavicol, nerol, geraniol, and citral. Tulsi is a good source of antioxidants and offers substantial protection against free radical-induced damage.6 This damage has been involved in several oxidative stress-related diseases, such as liver cirrhosis, atherosclerosis, cancer, and diabetes.7–10 It has been identified that basil can also inhibit lipid peroxidation and increase the activity of superoxide dismutase.11 The presence of eugenol is attributed to its antioxidative property and is also thought to be responsible for
Manuscript received 6 August 2014. Revision accepted 20 January 2015. Address correspondence to: Chandrakala Aluganti Narasimhulu, PhD, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA, E-mail: [email protected]
507
508
NARASIMHULU AND VARDHAN
from other peroxidases is its ability to generate hypochlorous acid that may mediate formation of distinct chlorinated derivatives. Furthermore, its effects on lysine, methionine, and tyrosine residues within proteins may have additional effects on the tertiary structure and function of proteins. Therefore, MPO of inflammatory cells has considerable potential to cause tissue damage. It is also known that MPO converts LDL into a proatherogenic form within the artery wall. A role for this enzyme in the oxidation of apolipoprotein A1 (Apo A1) of HDL has also been recognized. The oxidation of critical amino acid residues of Apo A1 has been shown to reduce the cholesterol efflux function of HDL.25–27 Inflammation plays a major role in the progression of atherosclerosis, and oxidized (Ox)-LDL/HDL-triggered inflammation is considered to be one of the major causes of atherosclerosis. In this study, we determined the antioxidant property of the basil leaf aqueous extract on lipoproteins and its anti-inflammatory property on lipopolysaccharide (LPS)induced inflammation in vitro. MATERIALS AND METHODS Chemicals All chemicals were purchased from Sigma Chemicals (St. Louis, MO, USA); pimers and cell culture reagents were purchased from Invitrogen (Carlsbad, CA, USA). Preparation of crude basil leaf extract Basil extract (BE; aqueous) was prepared by macerating 10 g of dried basil leaf powder with 100 mL sterilized water and then filtered through Wattman filter paper. The filtrate was lyophilized and reconstituted with 10 mL of sterilized water. Approximately 2 lg of extract was used to run the spectrum between 200 and 300 nm. The spectra for eugenol and ursolic acid were also run at the same wavelength scan (data not shown). Isolation and oxidation of lipoproteins The study protocol was approved by the University of Central Florida Institutional Review Board. Blood was collected in heparinized tubes from consenting healthy donors and stored on ice. Blood was centrifuged at 450 g for 20 min and plasma was separated. Lipoproteins were isolated from normal plasma by sequential ultracentrifugation using a Beckman TL-100 tabletop ultracentrifuge (Beckman, Palo Alto, CA, USA).28 The isolated lipoproteins were dialyzed against 0.3 mM EDTA in 1 · phosphate-buffered saline (PBS) of pH 7.4 overnight and subsequently filter sterilized. The amount of protein was estimated using the Bio-Rad DC protein assay (Hercules, CA, USA). The LDL/ HDL sample was subjected to oxidation immediately after dialysis. Oxidation of LDL/HDL was performed29 with 5 lM copper or MPO (0.2 U) and 100 lM H2O2 to a 100 lg/mL of LDL in 1 mL of PBS at 37C both in the presence and absence of different concentrations of either basil extract (2– 50 lg) or its components, eugenol or ursolic acid (5–25 lM). The formation of conjugated dienes was monitored at
an optical density of 234 nm for about 4–6 h using the SLM Aminco DB-3500 spectrophotometer (Urbana, IL, USA) equipped with a 12-chamber cuvette changer. The degree of LDL/HDL oxidation was assessed by determination of peroxide content using leucomethylene blue (LMB) assay30 and thiobarbituric acid reactive substance (TBARS) assay.31 Electrophoretic mobility of Ox-LDL was determined by using agarose gel electrophoresis. Preparation of HPODE and incubation with basil extract, eugenol, and ursolic acid 13-Hydroperoxylinoleic acid (13-HPODE)32 of 200 nmoles/mL was prepared and used to determine the effect of the whole basil extract and its components, eugenol and ursolic acid, on free fatty acid peroxides (FFAOOHs). HPODE was incubated with increasing concentrations of basil extract (2–20 lg), eugenol (1–10 lM), and ursolic acid (5–25 lM) for 1 h at room temperature. Lipid peroxide generated in the reaction system was analyzed by LMB assay.30 Cell culture RAW 264.7 cells were obtained from ATCC. Cells were grown as a monolayer in flasks and dishes and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (Sigma Chemicals), 2 mM l-glutamine, and 1 · penicillin– streptomycin antibiotic solution. Cultures were maintained in a 5% CO2 atmosphere at 37C. For experiments, the cells were starved in a serum-free medium. WST-1 for cell viability assay Cells (2.5 · 103 cells/100 lL) were seeded in a 96-well plate and incubated overnight at 37C under a 5% CO2 atmosphere. The medium in the wells was then replaced with fresh medium containing whole basil leaf extract (5–100 lg) and its components, eugenol and ursolic acid (1–50 lM), and incubated for 24 h. The effect of the basil leaf extract and its components on cell viability was determined by WST-1 assay (Roche Applied Science, Indianapolis, IN, USA). Briefly, 10 lL of WST-1 reagent, which is processed to formazan by cellular enzymes, was added to each well in 100 lL of cell culture medium, and the plates were further incubated for 4 h at 37C. Cell viability was calculated by measuring absorbance at 450 and 630 nm as reference wavelengths using a 96-well plate reader (Bio-Rad). Incubation of RAW 264.7 cells with LPS in the presence and absence of eugenol/BE/UA To monitor the changes in gene expression of tumor necrosis factor-a (TNF-a), interleukin (IL)-1a, IL-1b, and IL-6, RAW 264.7 cells (2 · 105 cells/well) were incubated in serum-free RPMI 1640 for 4 h. Ten millimolar concentrations of eugenol and ursolic acid were prepared in PBS and used. Cells were pretreated with 5 and 25 lM of eugenol and ursolic acid, 10 and 50 lg of BE for 2 h, followed by addition of 10 ng/mL LPS. At the end of the 24-h incubation, cells were harvested in Trizol for RNA isolation.
509
OCIMUM TENUIFLORUM AS MPO INHIBITOR Table 1. List of Oligonucleotide Primers Used for Real Time-Polymerase Chain Reaction Species Mouse
Target IL-1a IL-1b IL-6 TNF-a GAPDH
Forward primer 0
Reverse primer 0
5 -GCAACGGGAAGATTCTGAAG-3 50 -AACCTGCTGGTGTGTGACTTC-30 50 -AGTTGCCTTCTTGGGACTGA-30 50 -CACACTCAGATCATCTTCCAAAA-30 50 -ACCCAGAAGACTGTGGATGG-30
0
5 -TGACAAACTTCTGCCTGACG-30 50 -CAGCACGAGGCTTTTTTGT-30 50 -TCCACGATTTCCCAGAGAAC-30 50 -GCAATGACTCTAAGTAGACCTGC-30 50 -CACATTGGGGGTAGGAACAC-30
IL, interleukin; TNF-a, tumor necrosis factor-a.
Thin-layer chromatography and SDS-PAGE for aqueous extract An amount of 5 lL of basil extract (2 mg/mL), eugenol, and ursolic acid (5 mg/mL in chloroform) were loaded onto silica G thin-layer chromatography (TLC) plates and fluorescent plates using chloroform/ethylacetate/acetic acid (10:2.5:0.05 v/v) as
the solvent system. Visualization of the components was carried out with a brief exposure to iodine vapors and with FeCl3 for visualization of fluorescent spots from unsaturated compounds. Twelve percent sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) was used to determine the protein content in basil aqueous extract by both coomassie staining and silver staining.
FIG. 1. Basil extract (BE) and its components inhibit the oxidation of lipoproteins by copper. Lipoproteins were isolated from the plasma of consenting subjects and used for oxidation with copper. One hundred micrograms of low- or high-density lipoprotein (LDL/HDL) was pretreated with BE (10 and 50 lg) and its components, eugenol and ursolic acid (UA), at different concentrations (5 and 25 lM) for 1 h at room temperature, and then oxidation was performed with 5 lM copper in 1 mL phosphate-buffered saline (PBS); OD was measured at 234 nm. As concentrations of BE (Ai, ii), eugenol (Bi, ii), and UA (Ci, ii) increased, initiation of LDL/high-density lipoprotein (HDL) oxidation was delayed.
510
NARASIMHULU AND VARDHAN
cDNA synthesis and real time-polymerase chain reaction Total RNA from cells was isolated by using Trizol reagent. One microgram of RNA was reverse transcribed into cDNA using the Superscript III First-Strand Synthesis system (Invitrogen). cDNA (50 ng) sample was used to perform quantitative real-time PCR reaction by the iQTM5 iCycler Multicolor Real-Time PCR Detection system (BioRad) with SYBR Green (Invitrogen). Polymerase chain reaction (PCR) was carried out with IL-1a, IL-1b, IL-6, and TNF-a-specific primers for mouse (Table 1), resulting in 200- and 400-bp fragments. As a reference gene, we used GAPDH primers, resulting in a 200-bp fragment. PCR was performed with an initial step of denaturation at 50C for 2 min, 95C for 10 min, followed by 40 cycles at 95C for 20 sec, and 60C for 20 sec. Melt curves were established for the reactions. Normalized fold expression was calculated by using the 2 - DDCt method. The entire reaction product was electrophoresed on 2% agarose gels. Experiments were repeated more than three times.
Inhibition of peroxidase activity of MPO by basil extract and eugenol MPO activity was measured colorimetrically by oxidation of substrate guaiacol and monitored by absorbance at 470 nm.33 A reaction volume of 200 lL contained 25– 100 ng of basil extract, 0.25–10 lM eugenol in phosphate buffer (pH 7.4), 0.5 lmoles guaiacol, 10 nmoles H2O2, and 0.1 U of MPO. The change in optical density at 470 nm was measured over 5 min using a 96-well plate reader (Bio-Rad). Relative MPO activity was calculated and used. MPO activity was also measured colorimetrically by oxidation of substrate TMB (3,30 ,5,50 -tetramethylbenzidine) and monitored by absorbance at 650 nm.34 A reaction volume of 200 lL contained 25–100 ng of basil extract, 0.25– 10 lM eugenol and ursolic acid, 50 mM sodium acetate buffer (pH 5.6), 25 nmoles TMB, 400 nmoles H2O2, and 0.02 mU of MPO. The change in optical density at 650 nm was measured every 10 min using a 96-well plate reader (Bio-Rad). Relative MPO activity was calculated and used.
FIG. 2. Basil extract and its components inhibit the oxidation of lipoproteins by myeloperoxidase (MPO). Lipoproteins were isolated from the plasma of consenting subjects and used for oxidation with copper. One hundred micrograms of LDL/HDL was pretreated with BE (10 and 50 lg), and its components, eugenol and ursolic acid, at different concentrations (5 and 25 lM), were incubated for 1 h at room temperature, and then oxidation was performed with 0.2 U MPO in 1 mL PBS; OD was measured at 234 nm. As concentration/volume of BE (A i, ii), eugenol (B i, ii), and UA (C i, ii) increased, except in UA, initiation of LDL/HDL oxidation was delayed in the presence of both BE and eugenol.
OCIMUM TENUIFLORUM AS MPO INHIBITOR
Statistical analyses Values are presented as mean – standard deviation, and statistical analyses were performed by using Student’s t-test at significance of P < .05. RESULTS
511
and its components, eugenol and UA. Cells were incubated with BE (5–100 lg) and its components, eugenol and UA (1–50 lM), for 24 h and used for the assay as described in the Materials and Methods section. Percentage of cell viability was calculated using control as 100% viability. As shown in the Supplementary Figure S4, BE and eugenol have no obvious toxic effects on macrophages, whereas
Basil extract and its components, eugenol and ursolic acid, inhibit the oxidation of lipoproteins (LDL and HDL) To test the effect of BE and its components on the oxidation of LDL, the lipoprotein was incubated with 5 lM copper or 0.2 U MPO, and oxidation was performed in the presence and absence of different concentrations of BE, eugenol, and ursolic acid. The formation of conjugated dienes was measured by following the increase in absorption at 234 nm.35 As shown in Figure 1, control incubation generated an oxidized LDL that reached maximum increase in absorption at about 200 min. The lag phase, which represents the time at which antioxidants are consumed, was 60–80 min. As shown in Figures 1 and 2, in the presence of increasing amounts of either basil extract or eugenol/UA, there was an increase in lag time, suggesting that even low concentrations are able to delay the oxidation rate. Reduced thiobarbituric reactive substances were observed in the presence of BE and eugenol/UA compared with Ox-LDL, as shown in Supplementary Figures S1 and S2 (Supplementary Data are available online at www.liebertpub.com/jmf). Basil extract and its components, eugenol/UA, were also tested on HDL oxidation in the presence and absence of 5 lM copper (Fig. 1) or 0.2 U MPO, as shown in Figure 2. Similar results as seen with Ox-LDL were observed. Reduction of peroxides in the presence of BE/eugenol/UA FFAOOHs were reduced into hydroxides in the presence of increasing concentrations of basil extract and eugenol. As shown in Figure 3, both components showed a significant reduction in the peroxide content of FFAOOHs with increasing concentration, whereas ursolic acid did not show any effect on peroxide decomposition (Fig. 3). TLC and SDS-PAGE for BE component identification and protein determination In BE, spots corresponding to eugenol were observed with iodine staining, whereas the ursolic acid spot was not observed. Similarly, with FeCl3 staining for unsaturated compounds, only the eugenol spot was observed, whereas the others were not seen. The aqueous extract components are less polar than the corresponding components as shown in Figure 4. Basil extract was further analyzed by SDS-PAGE gel to determine the protein components. After confirming the absence of considerable protein content (Supplementary Fig. S3), basil extract was used for in vitro cell culture studies. Cell viability assay A WST-1 assay was used to evaluate the cell viability of RAW 264.7 macrophages in the presence and absence of BE
FIG. 3. Decomposition of HPODE in the presence of BE and its components. Two hundred nmoles per mL of HPODE was prepared by oxidizing linoleic acid with soybean lipoxygenase and used to determine the effect of BE and its components on free fatty acid peroxides (FFAOOHs). HPODE was incubated with increasing volume/ concentrations of (A) BE (2–20 lg) or (B) eugenol (1 and 10 lM) or (C) UA (5 and 25 lM) for 1 h at 37C. Lipid peroxide generated in the reaction system was analyzed by leucomethylene blue (LMB) assay. Except UA, both BE and eugenol showed significant reduction in the peroxide content of FFAOOHs in a concentration-dependent manner. *P < .05.
512
NARASIMHULU AND VARDHAN
FIG. 4. Thin-layer chromatography for BE and its components. Dotted circle represents the corresponding spot of eugenol.
UA at higher concentrations has a slight, but insignificant, toxic effect. Basil extract and its components attenuate LPS-induced IL-1a, IL-1b, IL-6, and TNF-a mRNA expression As seen in Figure 5, BE and its components attenuated LPS (10 ng/mL)-induced proinflammatory markers (Fig. 5A: IL-1a, Fig. 5B: IL-1b, Fig. 5C: IL-6; Fig. 5D: TNF-a) in RAW cells to varying degrees. Significant attenuation was observed with BE, whereas eugenol and UA were less effective at the concentration used. As shown in Figure 5E, PCR products also corroborated the gene studies. MPO activity The effect of BE and eugenol on MPO activity was studied. As shown in Figure 6, MPO activity was completely inhibited in the presence of BE and eugenol in a dosedependent manner with both substrates, guaiacol (6Ai and ii) and TMB (6Bi and Bii). DISCUSSION Oxidative stress plays a significant role in the pathogenesis of several cardiovascular diseases. Current experimental and
clinical studies suggest that O. tenuiflorum (commonly known as basil or Tulsi) possesses many health benefits. Oxidation of lipids is assumed to be implicated in the pathophysiology of atherosclerosis. It has been suggested that scavenging of lipid peroxyl radicals contributes to the antiatherosclerotic effects of naturally occurring compounds such as polyphenols. These compounds are capable of inhibiting the lipoprotein oxidation in vitro and suppressing the formation of plasma lipid oxidation products in vivo.32 Therefore, inhibition of LDL oxidation might be an important step in preventing atherosclerosis. Humans are protected from reactive oxygen species, in part, by absorption of dietary antioxidants.36 The ability of BE and its components to inhibit the oxidation of LDL by copper or MPO in an in vitro system suggests that they could prevent the formation of Ox-LDL in vivo. While this is interesting, numerous other antioxidants may also act more effectively and more inexpensively. This might be due to the ability of basil extract and its components to decrease the rate of initiation of oxidation by reacting with oxygen radicals. They might also act as chain terminators and prevent propagation of oxidation. Pretreatment of LDL with basil extract and its components renders LDL resistant to oxidation, suggesting that these compounds
OCIMUM TENUIFLORUM AS MPO INHIBITOR
513
FIG. 5. Basil extract and its components attenuate lipopolysaccharide (LPS)-induced proinflammatory gene expressions in RAW 264.7 cells. RAW 264.7 cells were incubated with BE (50 lg) and eugenol/UA (25 lM) for 2 h, followed by LPS (10 ng/mL) for 24 h. RNA was isolated and Real Time-PCR analysis was performed for (A) interleukin (IL)-1a, (B) IL-1b, (C) IL-6, and (D) tumor necrosis factor-a (TNF-a) gene expressions using appropriate primers. BE was effective in attenuating LPS-induced inflammatory markers, while the other two components were not effective in reducing proinflammatory gene expressions. (E) Polymerase chain reaction products. Results are represented as mean – standard deviation from more than three independent experiments. *P < .05.
might be able to remove 13(S)-HPODE and 15(S)-HPETE from LDL, which are the major enhancers of the nonenzymatic oxidation of both 1-palmitoyl-2-arachidonoylsn-glycero-3-phosphocholine and cholesterol linoleate.37,38 It is assumed that MPO secreted in the extracellular fluid is responsible for the generation of Ox-LDL, and whether peroxidized lipids formed on the cell membranes during ischemia/reperfusion injury may also be responsible could only be speculated. HDL plays a major role in reverse cholesterol transport (RCT) and may carry not only cholesterol but also phospholipids and oxidized lipids from foam cells. HDL has several functions beyond its role as an agent of RCT. It interferes with the oxidative modification of LDL (although it is also readily oxidized) and has enzymes such as paraoxonase 1 (PON1) associated with it. It is also reported to
bind and reduce peroxides.39 These putatively beneficial properties and the association of proinflammatory serum amyloid A and MPO has given rise to the concept of functionality of HDL. MPO-Ox-HDL, as MPO has been identified as an APOA 1 modifier under oxidative stress conditions, can lead to loss of anti-inflammatory and antioxidant properties of HDL and change to be proinflammatory in nature in vivo. Prevention of HDL oxidation by these components will retain all its native functions in addition to RCT, such as the anti-inflammatory, antithrombotic, cytoprotective, anti-infectious, and vasodilatory natures. The ability of BE and its components to reduce FFAOOHs is exciting and could have a major impact in preventing propagation of oxidation as well as in reducing the cellular effects of lipid peroxides. Eugenol is a compound containing
514
NARASIMHULU AND VARDHAN
FIG. 6. MPO activity. MPO activity was performed for BE (i) and eugenol (ii) using different substrates (A): Guaiacol (B): TMB. MPO activity was completely inhibited in the presence of BE and eugenol in a dose-dependent manner with both substrates.
methoxyphenol, which is a major source of many of the drugs of dentistry. Evidence suggests that the compounds associated with this group have the capacity to act as MPO inhibitors. We also tested the effect of guaiacol, which is a precursor for eugenol, and vanillin, also considered as an oxidizer, has shown similar effect on peroxide formation at a higher concentration (data not shown). This might be due to the presence of a methoxy group, which acts as an MPO inhibitor also inhibiting the soybean lipoxidase action. There is a reasonable homology of soybean lipoxidase with human 15 lipoxygenase and myeloperoxidase showing *19.9% and 11% similarity, respectively. LPS is an endotoxin that is an integral structural component of the outer membrane of gram-negative bacteria. It is released during cell division, cell death, or during antibiotic treatment against bacterial infection and leads to activation of macrophages and enhanced production of proinflammatory cytokines.40 Although generation of proinflammatory cytokines is essential for the development of the local inflammatory response, an unbalanced and sustained overproduction of such cytokines may lead to septic shock characterized by endothelial damage, loss of vascular tone, coagulopathy, and multiple system organ failure, often resulting in death.41 It has been identified that eugenol and ursolic acid prevent LPSinduced cytokine induction in macrophages at a higher concentration, particularly above 50 lM.22,42 Oxidative stress and inflammation are closely associated in atherosclerosis. At what stage of the disease inflammation plays a pivotal role is unknown. The results of our study suggest that basil extract and its components are able to inhibit the oxidation of LDL, and BE is able to attenuate LPS-induced inflammation more than its individual com-
ponents. Basil leaves can be simple nonpharmacological agents, which could prove invaluable as an adjunct therapy in the treatment of cardiovascular diseases. This study will form the basis for many future studies not only in atherosclerosis but also in other oxidative stress-related diseases, including diabetes, cancer, obesity, and hypertension. AUTHOR DISCLOSURE STATEMENT No competing financial interests exist. REFERENCES 1. Mabberley DJ: The plant book: A portable dictionary of the higher plants of genera and families of angiosperms. J California Native Plant Soc 1997;30:1–36. 2. Chattopadhyay RR: A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethnopharmacol 1999; 67:367–372. 3. Prakash J, Gupta SK: Chemopreventive activity of Ocimum sanctum seed oil. J Ethanopharmacol 2000;72:29–34. 4. Umadevi P: Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy basil, Ocimum Sanctum (Tulasi). Indian J Exp Biol 2001;39:185–190. 5. Dev S: Ocimum sanctum Linn. In: Prime Ayurvedic Plant Drugs. Anamaya Publishers, New Delhi, 2006, pp. 326–332. 6. Ahmed M, Ahamed RN, Aladakatti RH, Ghosesawar MG: Reversible anti-fertility effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose content in rats. J Basic Clin Physiol Pharmacol 2002;13:51–59. 7. Banerjee S, Parashar R, Kumar A, Rao AR: Modulatory influence of alcoholic extract of Ocimum leaves on carcinogenmetabolizing enzyme activities and reduced glutathione levels in mouse. Nutr Cancer 1996;25:205–217.
OCIMUM TENUIFLORUM AS MPO INHIBITOR 8. Bansod S and Rai M: Antifungal activity of essential oils from indian medicinal plants against human pathogenic Aspergillus fumigatus and A. niger. World J Med Sci 2008;3:81–88. 9. Chattopadhyay RR: Hypoglycemic effect of O. sanctum leaf extract in normal and streptozotocin diabetic rats. Indian J Exp Biol 1993;31:891–893. 10. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin C: Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005;32:811–816. 11. Farid O, Amraoui EL, Zeggwagh NA, Eddouks M: Effect of Ocimum basilicum on glucose and lipids metabolism. In: Advances in Phytotherapy Research (Eddouks M, ed.). Research Signpost, India, 2009, pp. 187–200. 12. Gupta SK, Prakash J, Srivastava SV: Validation of claim of Tulsi, Ocimum sanctum Linn as a medicinal plant. Indian J Exp Biol 2002;40:765–773. 13. Markowitz K, Moynihan M, Liv M, Kim S: Biologic properties of eugenol and zinc oxide-eugenol. Oral Surg Oral Med Oral Pathol 1992;73:729–737. 14. IARC Monographs Evaluation of Carcinogenic Risk of Chemicals to Humans. Vol. 36, Lyon, France, 1985, pp. 75–97. 15. Wagner H, Jurcic K, Deininger R: Antispasmodic activity of eugenol-esters and-ethers. Planta Med 1979;37:9–14. 16. Feng J, Lipton JM: Eugenol: Antipyretic activity in rabbits. Neuropharmacology 1987;26:1775–1778. 17. Hume WR: Effect of eugenol on constrictor responses in blood vessels of the rabbit ear. J Dent Res 1983;62:1013–1015. 18. Moleyar V, Narasimham P: Antibacterial activity of essential oil components. Int J Food Microbiol 1992;16:337–342. 19. Raghavenra H, Diwakr BT, Lokesh BR, Naidu KA: Eugenol— The active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells. Prostaglandins Leukot Essent Fatty Acids 2006;74:23–27. 20. Goretti M, Silva V, Vieira IGP, Mendes FNP, Albuquerque IL, Santos RN, Silva FO, Morais SM: Variation of ursolic acid content in eight Ocimum species from northeastern Brazil. Molecules 2008;13:2482–2487. 21. Nataraju A, Gowda CDR, Rajesh R, Vishwanath BS: Group IIA secretory PLA2 inhibition by ursolic acid: A potent antiinflammatory molecule. Curr Top Med. Chem 2007;7:801–809. 22. Shin KM, Kim RK, Azefack TL, David L, Luc SB, Choudhary MI, Park HJ, Choi JW, Lee KT: In vitro anti-inflammatory activity of 23-hydroxyursolic acid isolated from Cussonia bancoensis in murine macrophage RAW 264.7 cells. Planta Med 2004;70:803–807. 23. Souza CE, Maitra D, Saed GM, Diamond MP, Moura AA, Pennathur S, Abu-Soud HM: Hypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseases. PLoS One 2011;6:e27641. 24. Gumiero A, Metcalfe CL, Pearson AR, Raven EL, Moody PC: Nature of the ferryl heme in compounds i and ii. J Biol Chem 2011;286:1260–1268. 25. Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL: Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 2009;284: 30825–30835. 26. Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW: Modifying apolipoprotein a-i by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol
27.
28.
29.
30.
31.
32.
33.
34.
35. 36.
37.
38.
39.
40. 41. 42.
515
efflux by the abca1 pathway. J Biol Chem 2010;285:18473– 18484. Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, Heinecke JW: Myeloperoxidase impairs abca1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein a-i. J Biol Chem 2006; 281:9001–9004. Santanam N, Parthasarathy S: Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J Clin Invest 1995;95:2594–2600. Chandrakala AN, Sukul D, Selvarajan K, Sai-Sudhakar C, Sun B, Parthasarathy S: Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: Relevance to ischemic heart failure. Am J Physiol Cell Physiol 2012;302:C165–C177. Auerbach BJ, Kiely JS, Cornicelli JA.: A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem 1992;201:375–380. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883–3887. Khan-Merchant N, Penumetcha M, Meilhac O, Parthasarathy S: Oxidized fatty acids promote atherosclerosis only in the presence of dietarycholesterol in low-density lipoprotein receptor knockout mice. J Nutr 2002;132:3256–3262. Desser RK, Himmelhoch SR, Evans WH, Januska M, Mage M, Shelton E: Guinea pig heterophil and eosinophil peroxidase. Arch Biochem Biophys 1972;148:452–465. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345–352. Stocker R, Keaney JF Jr.: Role of oxidative modification in atherosclerosis. Physiol Rev 2004;84:138–478. Kamiya K, Tanaka Y, Endang H: Chemical constituents of Morinda citrifolia fruits inhibit copper induced low-density lipoprotein oxidation. J Agric Food Chem 2004;52:5843–5848. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3. J Lipid Res 2000;41:1495–1508. Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1. J Lipid Res 2000;41:1481–1494. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions a possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581–1590. Hancock RE, Scott MG: The role of antimicrobial peptides in animal defense Proc Natl Acad Sci USA 2000;97:8856–8861. Cohen J: The immunopathogenesis of sepsis. Nature 2002;420: 885–891. Bachiega TF, de Sousa JP, Bastos JK, Sforcin JM: Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. J Pharm Pharmacol 2012;64:610–616.
FULL COMMUNICATIONS
Therapeutic Potential of Ocimum tenuiflorum as MPO Inhibitor with Implications for Atherosclerosis Prevention Chandrakala Aluganti Narasimhulu and Sangamithra Vardhan Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA. ABSTRACT Current experimental studies show that Ocimum tenuiflorum (commonly known as basil or Tulsi) possesses many health benefits. Ocimum is suggested to be antioxidative and anti-inflammatory. Eugenol, an orthomethoxyphenol, and ursolic acid have been identified as important components of basil. Myeloperoxidase (MPO), an oxidative enzyme, has been implicated in the pathogenesis of atherosclerosis. MPO-dependent oxidation of lipoproteins has been implicated in foam cell formation, dysfunctional HDL, and abnormalities in reverse cholesterol transport. Whole leaf extract of O. tenuiflorum and its major components, eugenol and ursolic acid, inhibit the oxidation of lipoproteins by myeloperoxidase/copper as measured by conjugated diene formation as well as by the thiobarbituric acid reactive substance (TBARS) assay. Whole basil leaf extract is able to attenuate the lipopolysaccharide-induced inflammation in RAW 264.7 cells compared with its components. In addition, whole basil leaf extract and eugenol inhibited MPO enzyme activity against synthetic substrates. Based on these results, we conclude that basil extract could act as an inhibitor of MPO and may serve as a nonpharmacological therapeutic agent for atherosclerosis.
KEY WORDS: eugenol inflammation lipopolysaccharide lipoproteins oxidation ursolic acid
inhibition of lipid peroxidation,12 but the mechanisms of action are not yet known. Eugenol (4-allyl-2-methoxyphenol) is a naturally occurring phenolic compound in basil, cinnamon, and nutmeg and is the major component of clove oil. It is widely used as a component of zinc oxide eugenol cement in dentistry and is applied to the oral environment.13 In addition, eugenol is a flavoring agent in cosmetic and food products.14 Eugenol has been shown to possess many medicinal properties, such as antispasmodic,15 antipyretic,16 anti-inflammatory,17 and antibacterial activities.18 Recently, it is reported that eugenol inhibits 5-lipoxygenase enzyme by a noncompetitive mechanism.19 Ursolic acid (UA) is another component associated with basil and was identified as the major component in O. tenuiflorum.20 It has been reported that ursolic acid has protective properties similar to that of basil. Several mechanisms have been proposed to explain its anti-inflammatory activity, including inhibition of secretory phospholipase (PLA2) enzymes21 and inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2).22 Existing evidence suggests that myeloperoxidase (MPO) plays a major role in the oxidative modification of both lowdensity lipoprotein (LDL) and high-density lipoprotein (HDL). MPO is a heme protein expressed at high levels in neutrophils, monocytes, and subpopulations of human macrophages. Catalytic activity of MPO is responsible for the generation of reactive intermediates that can promote further oxidation.23,24 One feature that distinguishes MPO
INTRODUCTION
P
lants have been the primary source of medicines for centuries. Several medicinal plants serve as potent sources of secondary metabolites and oils, which have gained therapeutic importance. Ocimum tenuiflorum is the queen of herbs, commonly known as holy basil or krishna tulsi.1 Numerous studies have reported various properties of Ocimum sp., including antimicrobial, adaptogenic, antidiabetic, hepatoprotective, anti-inflammatory, anticarcinogenic, radioprotective, immunomodulatory, neuroprotective, and cardioprotective, and its acting as a mosquito repellent.2–5 The major constituents in O. tenuiflorum are essential oils, carbohydrates, flavanoids, proline, high amount of linalool, and moderate amounts of methyl chavicol, nerol, geraniol, and citral. Tulsi is a good source of antioxidants and offers substantial protection against free radical-induced damage.6 This damage has been involved in several oxidative stress-related diseases, such as liver cirrhosis, atherosclerosis, cancer, and diabetes.7–10 It has been identified that basil can also inhibit lipid peroxidation and increase the activity of superoxide dismutase.11 The presence of eugenol is attributed to its antioxidative property and is also thought to be responsible for
Manuscript received 6 August 2014. Revision accepted 20 January 2015. Address correspondence to: Chandrakala Aluganti Narasimhulu, PhD, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA, E-mail: [email protected]
507
508
NARASIMHULU AND VARDHAN
from other peroxidases is its ability to generate hypochlorous acid that may mediate formation of distinct chlorinated derivatives. Furthermore, its effects on lysine, methionine, and tyrosine residues within proteins may have additional effects on the tertiary structure and function of proteins. Therefore, MPO of inflammatory cells has considerable potential to cause tissue damage. It is also known that MPO converts LDL into a proatherogenic form within the artery wall. A role for this enzyme in the oxidation of apolipoprotein A1 (Apo A1) of HDL has also been recognized. The oxidation of critical amino acid residues of Apo A1 has been shown to reduce the cholesterol efflux function of HDL.25–27 Inflammation plays a major role in the progression of atherosclerosis, and oxidized (Ox)-LDL/HDL-triggered inflammation is considered to be one of the major causes of atherosclerosis. In this study, we determined the antioxidant property of the basil leaf aqueous extract on lipoproteins and its anti-inflammatory property on lipopolysaccharide (LPS)induced inflammation in vitro. MATERIALS AND METHODS Chemicals All chemicals were purchased from Sigma Chemicals (St. Louis, MO, USA); pimers and cell culture reagents were purchased from Invitrogen (Carlsbad, CA, USA). Preparation of crude basil leaf extract Basil extract (BE; aqueous) was prepared by macerating 10 g of dried basil leaf powder with 100 mL sterilized water and then filtered through Wattman filter paper. The filtrate was lyophilized and reconstituted with 10 mL of sterilized water. Approximately 2 lg of extract was used to run the spectrum between 200 and 300 nm. The spectra for eugenol and ursolic acid were also run at the same wavelength scan (data not shown). Isolation and oxidation of lipoproteins The study protocol was approved by the University of Central Florida Institutional Review Board. Blood was collected in heparinized tubes from consenting healthy donors and stored on ice. Blood was centrifuged at 450 g for 20 min and plasma was separated. Lipoproteins were isolated from normal plasma by sequential ultracentrifugation using a Beckman TL-100 tabletop ultracentrifuge (Beckman, Palo Alto, CA, USA).28 The isolated lipoproteins were dialyzed against 0.3 mM EDTA in 1 · phosphate-buffered saline (PBS) of pH 7.4 overnight and subsequently filter sterilized. The amount of protein was estimated using the Bio-Rad DC protein assay (Hercules, CA, USA). The LDL/ HDL sample was subjected to oxidation immediately after dialysis. Oxidation of LDL/HDL was performed29 with 5 lM copper or MPO (0.2 U) and 100 lM H2O2 to a 100 lg/mL of LDL in 1 mL of PBS at 37C both in the presence and absence of different concentrations of either basil extract (2– 50 lg) or its components, eugenol or ursolic acid (5–25 lM). The formation of conjugated dienes was monitored at
an optical density of 234 nm for about 4–6 h using the SLM Aminco DB-3500 spectrophotometer (Urbana, IL, USA) equipped with a 12-chamber cuvette changer. The degree of LDL/HDL oxidation was assessed by determination of peroxide content using leucomethylene blue (LMB) assay30 and thiobarbituric acid reactive substance (TBARS) assay.31 Electrophoretic mobility of Ox-LDL was determined by using agarose gel electrophoresis. Preparation of HPODE and incubation with basil extract, eugenol, and ursolic acid 13-Hydroperoxylinoleic acid (13-HPODE)32 of 200 nmoles/mL was prepared and used to determine the effect of the whole basil extract and its components, eugenol and ursolic acid, on free fatty acid peroxides (FFAOOHs). HPODE was incubated with increasing concentrations of basil extract (2–20 lg), eugenol (1–10 lM), and ursolic acid (5–25 lM) for 1 h at room temperature. Lipid peroxide generated in the reaction system was analyzed by LMB assay.30 Cell culture RAW 264.7 cells were obtained from ATCC. Cells were grown as a monolayer in flasks and dishes and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (Sigma Chemicals), 2 mM l-glutamine, and 1 · penicillin– streptomycin antibiotic solution. Cultures were maintained in a 5% CO2 atmosphere at 37C. For experiments, the cells were starved in a serum-free medium. WST-1 for cell viability assay Cells (2.5 · 103 cells/100 lL) were seeded in a 96-well plate and incubated overnight at 37C under a 5% CO2 atmosphere. The medium in the wells was then replaced with fresh medium containing whole basil leaf extract (5–100 lg) and its components, eugenol and ursolic acid (1–50 lM), and incubated for 24 h. The effect of the basil leaf extract and its components on cell viability was determined by WST-1 assay (Roche Applied Science, Indianapolis, IN, USA). Briefly, 10 lL of WST-1 reagent, which is processed to formazan by cellular enzymes, was added to each well in 100 lL of cell culture medium, and the plates were further incubated for 4 h at 37C. Cell viability was calculated by measuring absorbance at 450 and 630 nm as reference wavelengths using a 96-well plate reader (Bio-Rad). Incubation of RAW 264.7 cells with LPS in the presence and absence of eugenol/BE/UA To monitor the changes in gene expression of tumor necrosis factor-a (TNF-a), interleukin (IL)-1a, IL-1b, and IL-6, RAW 264.7 cells (2 · 105 cells/well) were incubated in serum-free RPMI 1640 for 4 h. Ten millimolar concentrations of eugenol and ursolic acid were prepared in PBS and used. Cells were pretreated with 5 and 25 lM of eugenol and ursolic acid, 10 and 50 lg of BE for 2 h, followed by addition of 10 ng/mL LPS. At the end of the 24-h incubation, cells were harvested in Trizol for RNA isolation.
509
OCIMUM TENUIFLORUM AS MPO INHIBITOR Table 1. List of Oligonucleotide Primers Used for Real Time-Polymerase Chain Reaction Species Mouse
Target IL-1a IL-1b IL-6 TNF-a GAPDH
Forward primer 0
Reverse primer 0
5 -GCAACGGGAAGATTCTGAAG-3 50 -AACCTGCTGGTGTGTGACTTC-30 50 -AGTTGCCTTCTTGGGACTGA-30 50 -CACACTCAGATCATCTTCCAAAA-30 50 -ACCCAGAAGACTGTGGATGG-30
0
5 -TGACAAACTTCTGCCTGACG-30 50 -CAGCACGAGGCTTTTTTGT-30 50 -TCCACGATTTCCCAGAGAAC-30 50 -GCAATGACTCTAAGTAGACCTGC-30 50 -CACATTGGGGGTAGGAACAC-30
IL, interleukin; TNF-a, tumor necrosis factor-a.
Thin-layer chromatography and SDS-PAGE for aqueous extract An amount of 5 lL of basil extract (2 mg/mL), eugenol, and ursolic acid (5 mg/mL in chloroform) were loaded onto silica G thin-layer chromatography (TLC) plates and fluorescent plates using chloroform/ethylacetate/acetic acid (10:2.5:0.05 v/v) as
the solvent system. Visualization of the components was carried out with a brief exposure to iodine vapors and with FeCl3 for visualization of fluorescent spots from unsaturated compounds. Twelve percent sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) was used to determine the protein content in basil aqueous extract by both coomassie staining and silver staining.
FIG. 1. Basil extract (BE) and its components inhibit the oxidation of lipoproteins by copper. Lipoproteins were isolated from the plasma of consenting subjects and used for oxidation with copper. One hundred micrograms of low- or high-density lipoprotein (LDL/HDL) was pretreated with BE (10 and 50 lg) and its components, eugenol and ursolic acid (UA), at different concentrations (5 and 25 lM) for 1 h at room temperature, and then oxidation was performed with 5 lM copper in 1 mL phosphate-buffered saline (PBS); OD was measured at 234 nm. As concentrations of BE (Ai, ii), eugenol (Bi, ii), and UA (Ci, ii) increased, initiation of LDL/high-density lipoprotein (HDL) oxidation was delayed.
510
NARASIMHULU AND VARDHAN
cDNA synthesis and real time-polymerase chain reaction Total RNA from cells was isolated by using Trizol reagent. One microgram of RNA was reverse transcribed into cDNA using the Superscript III First-Strand Synthesis system (Invitrogen). cDNA (50 ng) sample was used to perform quantitative real-time PCR reaction by the iQTM5 iCycler Multicolor Real-Time PCR Detection system (BioRad) with SYBR Green (Invitrogen). Polymerase chain reaction (PCR) was carried out with IL-1a, IL-1b, IL-6, and TNF-a-specific primers for mouse (Table 1), resulting in 200- and 400-bp fragments. As a reference gene, we used GAPDH primers, resulting in a 200-bp fragment. PCR was performed with an initial step of denaturation at 50C for 2 min, 95C for 10 min, followed by 40 cycles at 95C for 20 sec, and 60C for 20 sec. Melt curves were established for the reactions. Normalized fold expression was calculated by using the 2 - DDCt method. The entire reaction product was electrophoresed on 2% agarose gels. Experiments were repeated more than three times.
Inhibition of peroxidase activity of MPO by basil extract and eugenol MPO activity was measured colorimetrically by oxidation of substrate guaiacol and monitored by absorbance at 470 nm.33 A reaction volume of 200 lL contained 25– 100 ng of basil extract, 0.25–10 lM eugenol in phosphate buffer (pH 7.4), 0.5 lmoles guaiacol, 10 nmoles H2O2, and 0.1 U of MPO. The change in optical density at 470 nm was measured over 5 min using a 96-well plate reader (Bio-Rad). Relative MPO activity was calculated and used. MPO activity was also measured colorimetrically by oxidation of substrate TMB (3,30 ,5,50 -tetramethylbenzidine) and monitored by absorbance at 650 nm.34 A reaction volume of 200 lL contained 25–100 ng of basil extract, 0.25– 10 lM eugenol and ursolic acid, 50 mM sodium acetate buffer (pH 5.6), 25 nmoles TMB, 400 nmoles H2O2, and 0.02 mU of MPO. The change in optical density at 650 nm was measured every 10 min using a 96-well plate reader (Bio-Rad). Relative MPO activity was calculated and used.
FIG. 2. Basil extract and its components inhibit the oxidation of lipoproteins by myeloperoxidase (MPO). Lipoproteins were isolated from the plasma of consenting subjects and used for oxidation with copper. One hundred micrograms of LDL/HDL was pretreated with BE (10 and 50 lg), and its components, eugenol and ursolic acid, at different concentrations (5 and 25 lM), were incubated for 1 h at room temperature, and then oxidation was performed with 0.2 U MPO in 1 mL PBS; OD was measured at 234 nm. As concentration/volume of BE (A i, ii), eugenol (B i, ii), and UA (C i, ii) increased, except in UA, initiation of LDL/HDL oxidation was delayed in the presence of both BE and eugenol.
OCIMUM TENUIFLORUM AS MPO INHIBITOR
Statistical analyses Values are presented as mean – standard deviation, and statistical analyses were performed by using Student’s t-test at significance of P < .05. RESULTS
511
and its components, eugenol and UA. Cells were incubated with BE (5–100 lg) and its components, eugenol and UA (1–50 lM), for 24 h and used for the assay as described in the Materials and Methods section. Percentage of cell viability was calculated using control as 100% viability. As shown in the Supplementary Figure S4, BE and eugenol have no obvious toxic effects on macrophages, whereas
Basil extract and its components, eugenol and ursolic acid, inhibit the oxidation of lipoproteins (LDL and HDL) To test the effect of BE and its components on the oxidation of LDL, the lipoprotein was incubated with 5 lM copper or 0.2 U MPO, and oxidation was performed in the presence and absence of different concentrations of BE, eugenol, and ursolic acid. The formation of conjugated dienes was measured by following the increase in absorption at 234 nm.35 As shown in Figure 1, control incubation generated an oxidized LDL that reached maximum increase in absorption at about 200 min. The lag phase, which represents the time at which antioxidants are consumed, was 60–80 min. As shown in Figures 1 and 2, in the presence of increasing amounts of either basil extract or eugenol/UA, there was an increase in lag time, suggesting that even low concentrations are able to delay the oxidation rate. Reduced thiobarbituric reactive substances were observed in the presence of BE and eugenol/UA compared with Ox-LDL, as shown in Supplementary Figures S1 and S2 (Supplementary Data are available online at www.liebertpub.com/jmf). Basil extract and its components, eugenol/UA, were also tested on HDL oxidation in the presence and absence of 5 lM copper (Fig. 1) or 0.2 U MPO, as shown in Figure 2. Similar results as seen with Ox-LDL were observed. Reduction of peroxides in the presence of BE/eugenol/UA FFAOOHs were reduced into hydroxides in the presence of increasing concentrations of basil extract and eugenol. As shown in Figure 3, both components showed a significant reduction in the peroxide content of FFAOOHs with increasing concentration, whereas ursolic acid did not show any effect on peroxide decomposition (Fig. 3). TLC and SDS-PAGE for BE component identification and protein determination In BE, spots corresponding to eugenol were observed with iodine staining, whereas the ursolic acid spot was not observed. Similarly, with FeCl3 staining for unsaturated compounds, only the eugenol spot was observed, whereas the others were not seen. The aqueous extract components are less polar than the corresponding components as shown in Figure 4. Basil extract was further analyzed by SDS-PAGE gel to determine the protein components. After confirming the absence of considerable protein content (Supplementary Fig. S3), basil extract was used for in vitro cell culture studies. Cell viability assay A WST-1 assay was used to evaluate the cell viability of RAW 264.7 macrophages in the presence and absence of BE
FIG. 3. Decomposition of HPODE in the presence of BE and its components. Two hundred nmoles per mL of HPODE was prepared by oxidizing linoleic acid with soybean lipoxygenase and used to determine the effect of BE and its components on free fatty acid peroxides (FFAOOHs). HPODE was incubated with increasing volume/ concentrations of (A) BE (2–20 lg) or (B) eugenol (1 and 10 lM) or (C) UA (5 and 25 lM) for 1 h at 37C. Lipid peroxide generated in the reaction system was analyzed by leucomethylene blue (LMB) assay. Except UA, both BE and eugenol showed significant reduction in the peroxide content of FFAOOHs in a concentration-dependent manner. *P < .05.
512
NARASIMHULU AND VARDHAN
FIG. 4. Thin-layer chromatography for BE and its components. Dotted circle represents the corresponding spot of eugenol.
UA at higher concentrations has a slight, but insignificant, toxic effect. Basil extract and its components attenuate LPS-induced IL-1a, IL-1b, IL-6, and TNF-a mRNA expression As seen in Figure 5, BE and its components attenuated LPS (10 ng/mL)-induced proinflammatory markers (Fig. 5A: IL-1a, Fig. 5B: IL-1b, Fig. 5C: IL-6; Fig. 5D: TNF-a) in RAW cells to varying degrees. Significant attenuation was observed with BE, whereas eugenol and UA were less effective at the concentration used. As shown in Figure 5E, PCR products also corroborated the gene studies. MPO activity The effect of BE and eugenol on MPO activity was studied. As shown in Figure 6, MPO activity was completely inhibited in the presence of BE and eugenol in a dosedependent manner with both substrates, guaiacol (6Ai and ii) and TMB (6Bi and Bii). DISCUSSION Oxidative stress plays a significant role in the pathogenesis of several cardiovascular diseases. Current experimental and
clinical studies suggest that O. tenuiflorum (commonly known as basil or Tulsi) possesses many health benefits. Oxidation of lipids is assumed to be implicated in the pathophysiology of atherosclerosis. It has been suggested that scavenging of lipid peroxyl radicals contributes to the antiatherosclerotic effects of naturally occurring compounds such as polyphenols. These compounds are capable of inhibiting the lipoprotein oxidation in vitro and suppressing the formation of plasma lipid oxidation products in vivo.32 Therefore, inhibition of LDL oxidation might be an important step in preventing atherosclerosis. Humans are protected from reactive oxygen species, in part, by absorption of dietary antioxidants.36 The ability of BE and its components to inhibit the oxidation of LDL by copper or MPO in an in vitro system suggests that they could prevent the formation of Ox-LDL in vivo. While this is interesting, numerous other antioxidants may also act more effectively and more inexpensively. This might be due to the ability of basil extract and its components to decrease the rate of initiation of oxidation by reacting with oxygen radicals. They might also act as chain terminators and prevent propagation of oxidation. Pretreatment of LDL with basil extract and its components renders LDL resistant to oxidation, suggesting that these compounds
OCIMUM TENUIFLORUM AS MPO INHIBITOR
513
FIG. 5. Basil extract and its components attenuate lipopolysaccharide (LPS)-induced proinflammatory gene expressions in RAW 264.7 cells. RAW 264.7 cells were incubated with BE (50 lg) and eugenol/UA (25 lM) for 2 h, followed by LPS (10 ng/mL) for 24 h. RNA was isolated and Real Time-PCR analysis was performed for (A) interleukin (IL)-1a, (B) IL-1b, (C) IL-6, and (D) tumor necrosis factor-a (TNF-a) gene expressions using appropriate primers. BE was effective in attenuating LPS-induced inflammatory markers, while the other two components were not effective in reducing proinflammatory gene expressions. (E) Polymerase chain reaction products. Results are represented as mean – standard deviation from more than three independent experiments. *P < .05.
might be able to remove 13(S)-HPODE and 15(S)-HPETE from LDL, which are the major enhancers of the nonenzymatic oxidation of both 1-palmitoyl-2-arachidonoylsn-glycero-3-phosphocholine and cholesterol linoleate.37,38 It is assumed that MPO secreted in the extracellular fluid is responsible for the generation of Ox-LDL, and whether peroxidized lipids formed on the cell membranes during ischemia/reperfusion injury may also be responsible could only be speculated. HDL plays a major role in reverse cholesterol transport (RCT) and may carry not only cholesterol but also phospholipids and oxidized lipids from foam cells. HDL has several functions beyond its role as an agent of RCT. It interferes with the oxidative modification of LDL (although it is also readily oxidized) and has enzymes such as paraoxonase 1 (PON1) associated with it. It is also reported to
bind and reduce peroxides.39 These putatively beneficial properties and the association of proinflammatory serum amyloid A and MPO has given rise to the concept of functionality of HDL. MPO-Ox-HDL, as MPO has been identified as an APOA 1 modifier under oxidative stress conditions, can lead to loss of anti-inflammatory and antioxidant properties of HDL and change to be proinflammatory in nature in vivo. Prevention of HDL oxidation by these components will retain all its native functions in addition to RCT, such as the anti-inflammatory, antithrombotic, cytoprotective, anti-infectious, and vasodilatory natures. The ability of BE and its components to reduce FFAOOHs is exciting and could have a major impact in preventing propagation of oxidation as well as in reducing the cellular effects of lipid peroxides. Eugenol is a compound containing
514
NARASIMHULU AND VARDHAN
FIG. 6. MPO activity. MPO activity was performed for BE (i) and eugenol (ii) using different substrates (A): Guaiacol (B): TMB. MPO activity was completely inhibited in the presence of BE and eugenol in a dose-dependent manner with both substrates.
methoxyphenol, which is a major source of many of the drugs of dentistry. Evidence suggests that the compounds associated with this group have the capacity to act as MPO inhibitors. We also tested the effect of guaiacol, which is a precursor for eugenol, and vanillin, also considered as an oxidizer, has shown similar effect on peroxide formation at a higher concentration (data not shown). This might be due to the presence of a methoxy group, which acts as an MPO inhibitor also inhibiting the soybean lipoxidase action. There is a reasonable homology of soybean lipoxidase with human 15 lipoxygenase and myeloperoxidase showing *19.9% and 11% similarity, respectively. LPS is an endotoxin that is an integral structural component of the outer membrane of gram-negative bacteria. It is released during cell division, cell death, or during antibiotic treatment against bacterial infection and leads to activation of macrophages and enhanced production of proinflammatory cytokines.40 Although generation of proinflammatory cytokines is essential for the development of the local inflammatory response, an unbalanced and sustained overproduction of such cytokines may lead to septic shock characterized by endothelial damage, loss of vascular tone, coagulopathy, and multiple system organ failure, often resulting in death.41 It has been identified that eugenol and ursolic acid prevent LPSinduced cytokine induction in macrophages at a higher concentration, particularly above 50 lM.22,42 Oxidative stress and inflammation are closely associated in atherosclerosis. At what stage of the disease inflammation plays a pivotal role is unknown. The results of our study suggest that basil extract and its components are able to inhibit the oxidation of LDL, and BE is able to attenuate LPS-induced inflammation more than its individual com-
ponents. Basil leaves can be simple nonpharmacological agents, which could prove invaluable as an adjunct therapy in the treatment of cardiovascular diseases. This study will form the basis for many future studies not only in atherosclerosis but also in other oxidative stress-related diseases, including diabetes, cancer, obesity, and hypertension. AUTHOR DISCLOSURE STATEMENT No competing financial interests exist. REFERENCES 1. Mabberley DJ: The plant book: A portable dictionary of the higher plants of genera and families of angiosperms. J California Native Plant Soc 1997;30:1–36. 2. Chattopadhyay RR: A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethnopharmacol 1999; 67:367–372. 3. Prakash J, Gupta SK: Chemopreventive activity of Ocimum sanctum seed oil. J Ethanopharmacol 2000;72:29–34. 4. Umadevi P: Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy basil, Ocimum Sanctum (Tulasi). Indian J Exp Biol 2001;39:185–190. 5. Dev S: Ocimum sanctum Linn. In: Prime Ayurvedic Plant Drugs. Anamaya Publishers, New Delhi, 2006, pp. 326–332. 6. Ahmed M, Ahamed RN, Aladakatti RH, Ghosesawar MG: Reversible anti-fertility effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose content in rats. J Basic Clin Physiol Pharmacol 2002;13:51–59. 7. Banerjee S, Parashar R, Kumar A, Rao AR: Modulatory influence of alcoholic extract of Ocimum leaves on carcinogenmetabolizing enzyme activities and reduced glutathione levels in mouse. Nutr Cancer 1996;25:205–217.
OCIMUM TENUIFLORUM AS MPO INHIBITOR 8. Bansod S and Rai M: Antifungal activity of essential oils from indian medicinal plants against human pathogenic Aspergillus fumigatus and A. niger. World J Med Sci 2008;3:81–88. 9. Chattopadhyay RR: Hypoglycemic effect of O. sanctum leaf extract in normal and streptozotocin diabetic rats. Indian J Exp Biol 1993;31:891–893. 10. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin C: Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005;32:811–816. 11. Farid O, Amraoui EL, Zeggwagh NA, Eddouks M: Effect of Ocimum basilicum on glucose and lipids metabolism. In: Advances in Phytotherapy Research (Eddouks M, ed.). Research Signpost, India, 2009, pp. 187–200. 12. Gupta SK, Prakash J, Srivastava SV: Validation of claim of Tulsi, Ocimum sanctum Linn as a medicinal plant. Indian J Exp Biol 2002;40:765–773. 13. Markowitz K, Moynihan M, Liv M, Kim S: Biologic properties of eugenol and zinc oxide-eugenol. Oral Surg Oral Med Oral Pathol 1992;73:729–737. 14. IARC Monographs Evaluation of Carcinogenic Risk of Chemicals to Humans. Vol. 36, Lyon, France, 1985, pp. 75–97. 15. Wagner H, Jurcic K, Deininger R: Antispasmodic activity of eugenol-esters and-ethers. Planta Med 1979;37:9–14. 16. Feng J, Lipton JM: Eugenol: Antipyretic activity in rabbits. Neuropharmacology 1987;26:1775–1778. 17. Hume WR: Effect of eugenol on constrictor responses in blood vessels of the rabbit ear. J Dent Res 1983;62:1013–1015. 18. Moleyar V, Narasimham P: Antibacterial activity of essential oil components. Int J Food Microbiol 1992;16:337–342. 19. Raghavenra H, Diwakr BT, Lokesh BR, Naidu KA: Eugenol— The active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells. Prostaglandins Leukot Essent Fatty Acids 2006;74:23–27. 20. Goretti M, Silva V, Vieira IGP, Mendes FNP, Albuquerque IL, Santos RN, Silva FO, Morais SM: Variation of ursolic acid content in eight Ocimum species from northeastern Brazil. Molecules 2008;13:2482–2487. 21. Nataraju A, Gowda CDR, Rajesh R, Vishwanath BS: Group IIA secretory PLA2 inhibition by ursolic acid: A potent antiinflammatory molecule. Curr Top Med. Chem 2007;7:801–809. 22. Shin KM, Kim RK, Azefack TL, David L, Luc SB, Choudhary MI, Park HJ, Choi JW, Lee KT: In vitro anti-inflammatory activity of 23-hydroxyursolic acid isolated from Cussonia bancoensis in murine macrophage RAW 264.7 cells. Planta Med 2004;70:803–807. 23. Souza CE, Maitra D, Saed GM, Diamond MP, Moura AA, Pennathur S, Abu-Soud HM: Hypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseases. PLoS One 2011;6:e27641. 24. Gumiero A, Metcalfe CL, Pearson AR, Raven EL, Moody PC: Nature of the ferryl heme in compounds i and ii. J Biol Chem 2011;286:1260–1268. 25. Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL: Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 2009;284: 30825–30835. 26. Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW: Modifying apolipoprotein a-i by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol
27.
28.
29.
30.
31.
32.
33.
34.
35. 36.
37.
38.
39.
40. 41. 42.
515
efflux by the abca1 pathway. J Biol Chem 2010;285:18473– 18484. Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, Heinecke JW: Myeloperoxidase impairs abca1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein a-i. J Biol Chem 2006; 281:9001–9004. Santanam N, Parthasarathy S: Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J Clin Invest 1995;95:2594–2600. Chandrakala AN, Sukul D, Selvarajan K, Sai-Sudhakar C, Sun B, Parthasarathy S: Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: Relevance to ischemic heart failure. Am J Physiol Cell Physiol 2012;302:C165–C177. Auerbach BJ, Kiely JS, Cornicelli JA.: A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem 1992;201:375–380. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883–3887. Khan-Merchant N, Penumetcha M, Meilhac O, Parthasarathy S: Oxidized fatty acids promote atherosclerosis only in the presence of dietarycholesterol in low-density lipoprotein receptor knockout mice. J Nutr 2002;132:3256–3262. Desser RK, Himmelhoch SR, Evans WH, Januska M, Mage M, Shelton E: Guinea pig heterophil and eosinophil peroxidase. Arch Biochem Biophys 1972;148:452–465. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345–352. Stocker R, Keaney JF Jr.: Role of oxidative modification in atherosclerosis. Physiol Rev 2004;84:138–478. Kamiya K, Tanaka Y, Endang H: Chemical constituents of Morinda citrifolia fruits inhibit copper induced low-density lipoprotein oxidation. J Agric Food Chem 2004;52:5843–5848. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3. J Lipid Res 2000;41:1495–1508. Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1. J Lipid Res 2000;41:1481–1494. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions a possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581–1590. Hancock RE, Scott MG: The role of antimicrobial peptides in animal defense Proc Natl Acad Sci USA 2000;97:8856–8861. Cohen J: The immunopathogenesis of sepsis. Nature 2002;420: 885–891. Bachiega TF, de Sousa JP, Bastos JK, Sforcin JM: Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. J Pharm Pharmacol 2012;64:610–616.
